View in-depth coverage of the 2025 AUA Annual Meeting from urologists and key opinion leaders.
Conference Coverage
Coverage of the major medical conferences that impact genitourinary oncology professionals.
Advertisement
2024
2023
2022
GU Oncology Now delivers the latest genitourinary oncology conference coverage, highlighting advancements in treatments and tech.
Get exclusive conference news straight to your inbox.
Knowledge Hub Spotlights
Curated clinical content based on conditions, therapies, and technologies
Roundtables
Clinical discussions with experts in the field
The panel concludes with a discussion on the complexities of interpreting ctDNA positivity in earlier-stage bladder cancer.
The panel considers the adoption of bladder-sparing protocols and the potential of biomarkers to guide risk stratification.
The panel debates the management of high-grade T1 bladder cancer with lymphovascular invasion and variant histology.
The panel pivots to complex considerations in bladder cancer treatment, weighing the promise of IO in BCG-naïve patients.
The panel shares how patient lifestyle, bladder symptoms, and other factors influence intravesical therapy selection.
The panel explores the challenges of delivering bladder-sparing therapies like gem/doce and TAR-200 in real-world settings.